Dental Extraction Management for Patients on Anticoagulants and Antiplatelets

Topic: Dental extraction planning for patients taking anticoagulants or antiplatelet drugs

Main drug groups: Warfarin, direct oral anticoagulants / DOACs, aspirin, clopidogrel, dual antiplatelet therapy, and combination antithrombotic therapy

German terms: Antikoagulanzien, Thrombozytenaggregationshemmer, Zahnextraktion, Blutungsrisiko, lokale Hämostase

Core dental role: prevent unnecessary thrombotic risk, control operative bleeding locally, and give clear postoperative instructions.

This article is for dental education only. Do not tell a patient to stop warfarin, a DOAC, aspirin, clopidogrel, or dual antiplatelet therapy before extraction without appropriate guidance. For many dental extractions, the safer approach is to continue antithrombotic therapy and use careful local haemostatic measures. Unnecessary interruption can expose the patient to stroke, myocardial infarction, stent thrombosis, pulmonary embolism, or other serious thrombotic events.

Dental extraction in patients taking anticoagulants or antiplatelet drugs is common. The dentist's task is not simply to stop the drug; it is to balance bleeding risk against thrombotic risk.

Most postoperative bleeding after dental extraction is manageable with local measures such as pressure, suturing, haemostatic packing, and clear postoperative instructions. Thrombotic events after inappropriate interruption may be life-threatening.

The key clinical principle is: do not stop antithrombotic therapy casually; assess the procedure, assess the drug, stage treatment when needed, and achieve local haemostasis before discharge.

• Best approach: continue therapy in many routine extraction cases and control bleeding locally.
• Main dental risk: postoperative oozing, delayed bleeding, or prolonged socket bleeding.
• Main medical risk if stopped: stroke, myocardial infarction, stent thrombosis, embolism, or recurrent vascular event.
• Key planning step: classify both drug risk and procedure bleeding risk.
• Clinical priority: stable haemostasis, written instructions, and clear emergency contact plan.

• Warfarin: check recent INR and treat only if it is within the accepted safe range for dental care according to local guidance.
• DOACs: apixaban, rivaroxaban, dabigatran, and edoxaban have rapid onset and offset; renal function and dosing time matter.
• Single antiplatelet therapy: aspirin or clopidogrel is usually continued for dental procedures.
• Dual antiplatelet therapy: usually not interrupted without specialist advice, especially after coronary stent placement.
• Combination therapy: anticoagulant plus antiplatelet therapy increases bleeding risk and often requires careful staging or medical consultation.

• Lower bleeding risk: simple extraction of a small number of teeth, small soft-tissue procedures, and limited subgingival treatment.
• Higher bleeding risk: multiple adjacent extractions, surgical extractions, flap raising, bone removal, periodontal surgery, implant surgery, biopsies, and large surgical fields.
• Patient factors that raise risk: previous postoperative bleeding, renal disease, liver disease, thrombocytopenia, uncontrolled hypertension, alcohol misuse, drug combinations, or poor follow-up ability.
• Practical rule: when risk is higher, reduce the surgical field, stage treatment, and prepare local haemostatic measures before starting.

• Confirm the indication for warfarin and check the most recent INR.
• Proceed only when INR is within the safe range accepted by local dental guidance.
• If INR is above the accepted range, delay invasive treatment and liaise with the anticoagulation clinic or physician.
• Do not reduce or stop warfarin without appropriate medical guidance.
• Use local haemostatic measures and provide clear postoperative instructions.

• Identify the DOAC: apixaban, rivaroxaban, dabigatran, or edoxaban.
• Confirm dose timing, renal disease, age, weight concerns, and drug interactions when relevant.
• For low-risk procedures, many patients can be treated without interruption according to guidance.
• For higher-risk procedures, guidance may recommend timing the procedure around the dose or missing/delaying a dose according to the specific DOAC and local protocol.
• Because DOACs act quickly, do not restart or continue dosing after surgery without considering stable haemostasis and the agreed plan.

• Single aspirin or clopidogrel therapy is usually continued for dental extractions.
• Dual antiplatelet therapy increases bleeding but is usually not stopped casually.
• Recent coronary stent, recent myocardial infarction, recent stroke, or recent acute coronary syndrome requires extra caution.
• Use staging, packing, sutures, pressure, and written instructions rather than unnecessary interruption.
• Consult the prescribing physician or cardiologist when the thrombotic risk is high or the procedure is extensive.

• Use atraumatic extraction technique and avoid unnecessary flap trauma.
• Remove inflamed granulation tissue when appropriate and irrigate carefully.
• Apply firm pressure with gauze for an adequate period.
• Use haemostatic packing such as oxidized cellulose, collagen sponge, gelatin sponge, or local protocol materials when indicated.
• Place sutures when wound size, surgical complexity, or drug risk justifies closure.
• Consider tranexamic acid local measures if available and appropriate under local protocol.
• Confirm stable haemostasis before the patient leaves the clinic.
• Give written instructions and emergency contact information.

• INR is above the accepted local threshold for dental treatment.
• Patient is taking multiple antithrombotic drugs and needs extensive surgery.
• Recent coronary stent, recent myocardial infarction, recent stroke, or recent venous thromboembolism.
• Complex oral surgery, multiple adjacent extractions, flap and bone removal, or implant surgery is planned.
• History of difficult postoperative bleeding.
• Severe renal disease, severe liver disease, thrombocytopenia, bleeding disorder, or uncontrolled hypertension.
• The medication history is unclear or the patient cannot state the drug name or dose.
• The clinic cannot provide safe haemostatic control or follow-up.

The biggest mistake is assuming that stopping the blood thinner is safer. In many patients, the bleeding risk from extraction is controllable, but the thrombotic risk from interruption may be catastrophic. Always ask: what happens if this patient stops the medication?

• Bite firmly on gauze for the instructed time.
• Do not rinse vigorously or spit repeatedly on the day of extraction.
• Avoid smoking, alcohol, hot drinks, strenuous exercise, and disturbing the clot.
• Use soft food and avoid chewing on the extraction site initially.
• If bleeding restarts, sit upright and apply firm pressure with clean gauze for the instructed period.
• Do not stop anticoagulant or antiplatelet medicine unless the medical plan says so.
• Use analgesics that are compatible with the patient's bleeding risk; avoid self-starting NSAIDs unless approved.
• Contact the clinic or emergency service if bleeding does not stop with pressure or if swallowing blood continues.

1. Ask when the bleeding started, whether the clot was disturbed, and what medication was taken.
2. Place the patient upright and apply firm pressure with gauze.
3. Inspect the socket and remove unstable clot only if needed for effective haemostasis.
4. Repack with local haemostatic material and suture if indicated.
5. Use local tranexamic acid measures when available and appropriate by protocol.
6. Escalate if bleeding remains uncontrolled, the patient is unstable, or systemic factors are suspected.
7. Document bleeding severity, drug history, local measures, advice, and follow-up plan.

Good extraction management is planned before the forceps touch the tooth: know the drug, know the procedure risk, prepare haemostatic materials, stage extensive work, and never discharge before haemostasis is stable.

• Bleeding does not stop after repeated firm pressure and local haemostatic measures.
• Large clots form repeatedly or the patient continues swallowing blood.
• Dizziness, fainting, weakness, pallor, tachycardia, or signs of haemodynamic concern.
• Known very high INR, severe liver disease, severe renal disease, or platelet disorder.
• Bleeding occurs with chest pain, neurological symptoms, or other systemic red flags.
• Patient has facial swelling, fever, spreading infection, or airway concern.
• Dental team cannot identify the antithrombotic regimen or cannot provide safe follow-up.

• Warfarin and Dental Treatment
• Apixaban and Dental Treatment
• Rivaroxaban and Dental Treatment
• Aspirin Antiplatelet Therapy and Dental Treatment
• Clopidogrel and Dental Treatment
• Dual Antiplatelet Therapy
• Tranexamic Acid Local Haemostasis
• Post-extraction bleeding
• Dental surgery planning
• Medical consultation in dentistry

Dental extraction in patients taking anticoagulants or antiplatelet drugs should be planned, not improvised. The dentist must identify the medication, understand the indication, classify the procedure bleeding risk, consider patient risk factors, and use local haemostatic measures. Warfarin requires an acceptable INR according to local guidance. DOAC management depends on procedure bleeding risk, dose timing, renal function, and local protocol. Aspirin, clopidogrel, and dual antiplatelet therapy are usually not stopped casually because thrombotic risk can be severe. Complex surgery, combination therapy, recent stent or thrombotic events, high INR, severe systemic disease, or unclear medication history should prompt consultation or staging. The safest extraction is one where haemostasis is planned before treatment, confirmed before discharge, and protected by clear postoperative instructions.